Natural killer cell lymphoma: Report of two pediatric cases, therapeutic options, and review of the literature

Cancer

Volumn 91, Issue 4, 2001, Pages 642-646

  Shaw, Peter H ^a   Cohn, Susan L ^a   Morgan, Elaine R ^a   Kovarik, Paula ^a   Haut, Paul R ^a   Kletzel, Morris ^a   Murphy, Sharon B ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Lymphoma; Natural killer cell; Pediatric; Stem cell transplantation; Therapy

Indexed keywords

ALPHA INTERFERON; ASPARAGINASE; BLEOMYCIN; CARBOPLATIN; CD2 ANTIGEN; CD33 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GALLIUM; HLA DR ANTIGEN; HYDROCORTISONE; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STAGING; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG MEGADOSE; HUMAN; LYMPHOMA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ANTIGENS, CD56; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA; MALE; SALVAGE THERAPY;

EID: 0035864997     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010215)91:4<642::AID-CNCR1047>3.0.CO;2-2     Document Type: Article

References (28)

1. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
2. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
3. Natural killer cell lymphoma/leukemia: Pathology and treatment
4. Treatment outcome and prognostic factors for primary nasal lymphoma
5. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas
6. Aggressive natural killer (NK) cell lymphoma: Report of a pediatric case and review of the literature
7. CD56 (NKH1)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules and angiocentricity
8. Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation
9. Aggressive primary natural killer cell lymphoma of the caecum: A case report and literature review
10. CD5- CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
11. Transplacental transmission of natural-killer-cell lymphoma
12. Report of the workshop on nasal and related extranodal angiocentric T/NK lymphomas: Definitions, differential diagnosis, and epidemiology
13. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia
14. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia
15. Treatment of childhood acute lymphoblastic leukemia: Results of Dana Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01
16. Classification of natural killer (NK) cell and NK-like T-cell malignancies
17. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract
18. Aggressive T/natural killer cell lymphoma presenting as testicular tumor
19. Aggressive natural killer cell lymphoma/leukemia: A recently recognised clinicopathologic entity
20. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin
21. The developmental relationship between NK cells and T cells
22. Identification of a common T/natural killer progenitor in human fetal thymus
23. A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells
24. Human natural killer cell committed thymocytes and their relation to the T cell lineage
25. Nasal and nasal-type natural killer/T-cell lymphoma
26. Lymphoblastic lymphoma of natural killer cell origin, presenting as pancreatic tumour
27. Natural killer-like T-cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes
28. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma